Age-dependent decline in remyelination capacity is mediated by apelin-APJ signaling

Nat Aging. 2021 Mar;1(3):284-294. doi: 10.1038/s43587-021-00041-7. Epub 2021 Mar 15.

Abstract

Age-related regeneration failure in the central nervous system can occur as a result of a decline in remyelination efficacy. The responsiveness of myelin-forming cells to signals for remyelination is affected by aging-related epigenetic modification; however, the molecular mechanism is not fully clarified. In the present study, we report that the apelin receptor (APJ) mediates remyelination efficiency with age. APJ expression in myelin-forming cells is correlated with age-associated changes in remyelination efficiency, and the activation of APJ promotes remyelination through the translocation of myelin regulatory factor. APJ signaling activation promoted remyelination in both aged mice with toxin-induced demyelination and mice with experimental autoimmune encephalomyelitis. In human cells, APJ activation enhanced the expression of remyelination markers. Impaired oligodendrocyte function in aged animals can be reversibly reactivated; thus, the results demonstrate that dysfunction of the apelin-APJ system mediates remyelination failure in aged animals, and that their myelinating function can be reactivated by APJ activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Apelin / genetics
  • Apelin Receptors / genetics
  • Humans
  • Mice
  • Myelin Sheath / metabolism
  • Remyelination* / physiology
  • Signal Transduction

Substances

  • Apelin
  • Apelin Receptors